Cargando…

Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study

Detalles Bibliográficos
Autores principales:	Chang, Anne Lynn S., Tran, Duy C., Cannon, John G. D., Li, Shufeng, Jeng, Mark, Patel, Roma, Van der Bokke, Lindsay, Pague, Alana, Brotherton, Richard, Rieger, Kerri E., Satpathy, Ansuman T., Yost, Kathryn E., Reddy, Sunil, Sarin, Kavita, Colevas, A. Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839543/ https://www.ncbi.nlm.nih.gov/pubmed/30145186 http://dx.doi.org/10.1016/j.jaad.2018.08.017

Ejemplares similares

AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma
por: Yao, Catherine D., et al.
Publicado: (2020)

Vismodegib: the Proof of Concept in Basal Cell Carcinoma
por: Berrada, Narjiss, et al.
Publicado: (2014)

Hidradenitis suppurativa in patients of color is associated with increased disease severity and healthcare utilization: A retrospective analysis of 2 U.S. cohorts
por: Kilgour, James M., et al.
Publicado: (2021)

Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics
por: Kilgour, James M., et al.
Publicado: (2021)

Clonal replacement of tumor-specific T cells following PD-1 blockade
por: Yost, Kathryn E., et al.
Publicado: (2019)

Treatment of Pyorrhea a Specialty
por: Pague, F. C.
Publicado: (1917)

Hidradenitis suppurativa and Ehlers-Danlos syndrome: A case-control study
por: Hua, Vivian J., et al.
Publicado: (2023)

c-FOS drives reversible basal to squamous cell carcinoma transition
por: Kuonen, François, et al.
Publicado: (2021)

Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry
por: Tabata, Mika M., et al.
Publicado: (2020)

Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study
por: Shen, Lujun, et al.
Publicado: (2020)

Skin basal cell carcinomas assemble a pro-tumorigenic spatially organized and self-propagating Trem2+ myeloid niche
por: Haensel, Daniel, et al.
Publicado: (2023)

Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
por: Taylor, Matthew H., et al.
Publicado: (2022)

Pembrolizumab
por: Khoja, Leila, et al.
Publicado: (2015)

Rolling the genetic dice: neutral and deleterious Smoothened mutations in drug-resistant basal cell carcinoma
por: Atwood, Scott X., et al.
Publicado: (2015)

Characterization of comorbidity heterogeneity among 13,667 patients with hidradenitis suppurativa
por: Hua, Vivian J., et al.
Publicado: (2021)

Pembrolizumab for all
por: Kim, Myung S., et al.
Publicado: (2022)

Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study
por: Sánchez-Conde, Matilde, et al.
Publicado: (2022)

LY6D marks pre-existing resistant basosquamous tumor subpopulations
por: Haensel, Daniel, et al.
Publicado: (2022)

Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy
por: Murakami, Shuji, et al.
Publicado: (2020)

Into the Clinic With Nivolumab and Pembrolizumab
por: Shu, Catherine A., et al.
Publicado: (2016)

Pembrolizumab-associated sarcoidosis
por: Cotliar, Jonathan, et al.
Publicado: (2016)

Pembrolizumab-induced pneumonitis
por: Leroy, Vincent, et al.
Publicado: (2017)

Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer
por: Mimura, Kaito, et al.
Publicado: (2022)

Bcl11a Controls Flt3 Expression in Early Hematopoietic Progenitors and Is Required for pDC Development In Vivo
por: Wu, Xiaodi, et al.
Publicado: (2013)

Proof-of-concept for intervention to prevent post-operative ileus in patients undergoing ileostomy formation
por: Greenberg, Anya L., et al.
Publicado: (2022)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
por: Park, Jonathan J., et al.
Publicado: (2023)

Exercise Increases Insulin Content and Basal Secretion in Pancreatic Islets in Type 1 Diabetic Mice
por: Huang, Han-Hung, et al.
Publicado: (2011)

Renal toxicities associated with pembrolizumab
por: Izzedine, Hassan, et al.
Publicado: (2018)

Pembrolizumab reactivates pulmonary granulomatosis
por: Al-dliw, Majdi, et al.
Publicado: (2017)

Pembrolizumab-induced bullous pemphigoid
por: Sun, Christina W., et al.
Publicado: (2019)

Pembrolizumab microgravity crystallization experimentation
por: Reichert, Paul, et al.
Publicado: (2019)

Association of Celiac Disease With Pembrolizumab
por: Sethi, Ashish, et al.
Publicado: (2021)

Molecular Farming of Pembrolizumab and Nivolumab
por: Stark, Michael C., et al.
Publicado: (2023)

Commentary on “Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data”
por: Colevas, A. Dimitrios
Publicado: (2017)

Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer
por: Ge, Xuan, et al.
Publicado: (2022)

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
por: Egelston, Colt A., et al.
Publicado: (2023)

Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen
por: Vardhana, Santosha A., et al.
Publicado: (2020)

PredCRG: A computational method for recognition of plant circadian genes by employing support vector machine with Laplace kernel
por: Meher, Prabina Kumar, et al.
Publicado: (2021)

Algebra of proofs
por: Szabo, M E, et al.
Publicado: (2016)

Basal cell adenocarcinoma of submandibular salivary gland-problems in cytologic diagnosis
por: Mardi, Kavita, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ajs9o8gnkhip7758nhrggd0edb